A chip-based platform 1,000x more sensitive than PCR — detecting disease up to 24 hours before any test on the market. From a raw sample. In under 60 seconds.

ZERO WAIT TIME | ZERO SAMPLE PREP | ZERO LAB REQUIRED 

Know in seconds, not days.

— DIAGNOSTICS, REINVENTED

27,000,000

People die every year from infectious disease. 80% of those deaths are preventable.

    1. GBD 2021 Sepsis (Lancet) — 21.4M sepsis-related deaths; combined with pneumonia (>2.5M, CIDRAP), TB (~1.3M, WHO 2023), and other infections. WHO Sepsis Fact Sheet; Global Sepsis Alliance.

    2. PMC Systematic Review (n=22,655) — 40.1% positive blood cultures = ~60% culture-negative despite clinical sepsis. ASM Clinical Microbiology Reviews — sensitivity typically 40–65%.

    3. Sepsis Alliance — Each hour of delay in appropriate antibiotics increases mortality 7–10%. CLSI Standards — Standard blood culture: 3–5 days to actionable result.

— WHAT WE BUILT

Labzero 101

Labzero built a portable testing platform that instantly detects microbes in real-world environments, without a lab, without sample prep, and without specialized training so people can make critical safety decisions in under a minute.

— DIAGNOSTICS, REINVENTED

What this means for you

— HOW IT WORKS

Collect. Tap. Know.

— APPLICATIONS

Same reader. Different chip.

Ready to know more?

Whether you're a partner, a clinician, a researcher, or someone who just believes
people deserve better — we'd love to hear from you.


Get in touch directly

Fill out the form and our team will get back to you within 24 hours.